Effect of repeated freeze-thaw cycles on maternal serum biological markers for the detection of fetal trisomies

被引:10
作者
Masse, J
Forest, JC
Moutquin, JM
Degrandpre, P
机构
[1] UNIV LAVAL,FAC MED,DEPT BIOCHEM,QUEBEC CITY,PQ G1K 7P4,CANADA
[2] UNIV LAVAL,FAC MED,DEPT OBSTET & GYNECOL,QUEBEC CITY,PQ G1K 7P4,CANADA
关键词
Down syndrome; free beta-human chorionic gonadotropin; alpha-fetoprotein; unconjugated estriol; stability;
D O I
10.1016/S0009-9120(97)00095-7
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: We studied the stability of maternal blood markers for screening for Down syndrome (alpha-fetoprotein, unconjugated estriol, intact human chorionic gonadotropin (hCG) and free beta-human chorionic gonadotropin) upon repeated freeze-thaw cycles. Design and Methods: Forty-three samples collected from second trimester normal pregnancies were submitted to five freeze-thaw cycles. After each cycle, the markers were measured using kits and instruments from Wallac Canada (Auto Delfia(R)). Results were compared by repeated measures analysis of variance and by analysis of linear trend (after mathematical transformation of the results in order to decrease between-sample variation) as a function of the number of freeze-thaw cycles. Results: No significant differences were observed by ANOVA (p > 0.1) for any marker. intact hCG showed a statistically significant linear downward trend (slope = -0.0063, p = 0.009) while free beta-hCG increased (slope = 0.011, p = 0.004). After five freeze-thaw cycles, a mean decrease of 3.2% is predicted for intact hCG while free beta-hCG would increase by 5.5% on average. Conclusion: We conclude that the studied markers do not show clinically significant changes under the evaluated conditions. The observed changes of intact hCG and free beta-hCG would have a limited impact on the screening performance.
引用
收藏
页码:527 / 530
页数:4
相关论文
共 18 条
[1]   THE DEACTIVATION OF HCG BY NICKING AND DISSOCIATION [J].
COLE, LA ;
KARDANA, A ;
PARK, SY ;
BRAUNSTEIN, GD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03) :704-710
[2]  
DEMEDEIROS SF, 1991, OBSTET GYNECOL, V77, P53
[3]   SCREENING FOR DOWN-SYNDROME DURING THE FIRST AND 2ND TRIMESTERS - IMPACT OF RISK-ESTIMATION PARAMETERS [J].
FOREST, JC ;
MASSE, J ;
ROUSSEAU, F ;
MOUTQUIN, JM ;
BRIDEAU, NA ;
BELANGER, M .
CLINICAL BIOCHEMISTRY, 1995, 28 (04) :443-449
[4]   Screening for Down syndrome during first trimester: A prospective study using free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A [J].
Forest, JC ;
Masse, J ;
Moutquin, JM .
CLINICAL BIOCHEMISTRY, 1997, 30 (04) :333-338
[5]   2ND-TRIMESTER MATERNAL SERUM SCREENING USING ALPHA-FETOPROTEIN, HUMAN CHORIONIC-GONADOTROPIN, AND UNCONJUGATED ESTRIOL - EXPERIENCE OF A REGIONAL PROGRAM [J].
GOODBURN, SF ;
YATES, JRW ;
RAGGATT, PR ;
CARR, C ;
FERGUSONSMITH, ME ;
KERSHAW, AJ ;
MILTON, PJD ;
FERGUSONSMITH, MA .
PRENATAL DIAGNOSIS, 1994, 14 (05) :391-402
[6]  
KARDANA A, 1992, CLIN CHEM, V38, P26
[7]  
KNIGHT GJ, 1991, CLIN CHEM, V37, P779
[8]   THE EFFECT OF SAMPLE PREPARATION AND STORAGE ON MATERNAL TRIPLE-MARKER SCREENING [J].
LANTZ, ME ;
OBRIEN, WF ;
WILLIAMS, MC .
OBSTETRICS AND GYNECOLOGY, 1995, 85 (06) :919-923
[9]   ANALYSIS OF SERIAL MEASUREMENTS IN MEDICAL-RESEARCH [J].
MATTHEWS, JNS ;
ALTMAN, DG ;
CAMPBELL, MJ ;
ROYSTON, P .
BRITISH MEDICAL JOURNAL, 1990, 300 (6719) :230-235
[10]  
MIZOUCHI T, 1985, JPN J CANCER RES, V76, P752